Skip to main content
Caplight Logo









Fraiya

Fraiya

Private
LondonHealthcare & Life Scienceshttps://www.fraiya.com/

Last Round

Pre Seed

Sep 9, 2025

Total Funding Raised

$4.86M

Momentum

Top 25%

of companies Caplight tracks

Company Overview

Fraiya is a healthcare technology company that develops AI-powered tools for pregnancy ultrasound to enhance diagnostic accuracy and efficiency.

Sector

Healthcare & Life Sciences

Verticals

Medical Imaging, Medical AI, Medical Devices, Clinical Trials

Business Model

B2B

Customer Profile

Subscription SaaS, Government Contracts, Services & Consulting

AI Layer

Application

Keywords

ultrasound AIprenatal screeningmedical imaging AIsoftware as a medical deviceSaMDultrasound copilotreal-time ultrasound assistancefetal anomaly detectionautomated fetal biometryobstetric imagingclinical decision supportNHS supplierCE marked medical deviceclinical trial technology

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Fraiya Comparables

Compare Fraiya with similar companies based on industry and business-model similarity.

Fraiya comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Diagnoly
89%
Prenaital
88%
DeepEcho
86%

Fraiya Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Pre SeedSep 9, 2025
AcceleratorAug 1, 2024

Key People

Founding team and executive leadership

Jackie Matthew

Co-Founder, Chief Medical Officer

Founding Team

Sam Budd

CTO & Co-Founder

Founding Team

Fraiya Investors

Notable investors and investment history

Fraiya investors
InvestorRounds
Raw VenturesPre Seed
Cedars Sinai Health VenturesPre Seed
Cedars-Sinai AcceleratorAccelerator

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jun 26, 2026

    Collaborating with King's College London on technology development.

  • Apr 25, 2026

    Grew 31% QoQ, from 13 to 17 employees.

Recent news

Latest coverage and updates

  • attends_eventJun 23, 2026

    Fraiya Ltd will attend event 23rd World Congress in Fetal Medicine on Jun 28th '26.

Fraiya Filings

Explore SEC and related filing metadata, where available.

Fraiya filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Fraiya's valuation, stock price, and market status.

Is Fraiya a public or private company?

Fraiya is a private company.

What is the current stock price of Fraiya?

Fraiya is a private company with no public stock price. No recent secondary market data is available.

How much is Fraiya worth (valuation)?

Valuation information for Fraiya is not publicly available.

Can I buy Fraiya stock?

Fraiya shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Fraiya's last funding round?

Funding round information for Fraiya is not publicly available.

Who are the main investors in Fraiya?

Investor information for Fraiya is not publicly disclosed.

Will Fraiya IPO soon?

No public IPO plans have been announced for Fraiya.

How can I track Fraiya secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Fraiya's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersLondon
Employee Range12
Year Founded2023
Last FundingSep 9, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?